loading

Finanzdaten der Kiora Pharmaceuticals Inc-Aktie (KPRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - 0.02
Operating Expenses
2.83%
2.3962
2.3304 2.5647 3.6022 2.5649
Operating Income/Loss
2.83%
-2.3962
-2.3304 -2.5647 -3.6022 -2.5449
Nonoperating Income/Loss
49.43%
0.1317
0.2604 0.4062 0.1889 0.3232
Income/Loss From Continuing Operations Before Tax
9.40%
-2.2645
-2.07 -10.36 -3.4133 0.02
Income Tax Expense/Benefit
191.10%
-0.1121
0.123 - - -
Income/Loss From Continuing Operations After Tax
1.85%
-2.1525
-2.193 -4.2235 -3.4133 -2.2216
Net Income/Loss
1.85%
-2.1525
-2.193 -4.2235 -3.4133 -2.2216
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5.41%
3.989
4.217 0.1152 4.215 4.1706
Diluted Average Shares
5.41%
3.989
4.217 0.0322 4.215 4.1706
Basic Earnings Per Share
3.85%
-0.54
-0.52 -1.15 -0.81 -0.53
Diluted Earnings Per Share
3.85%
-0.54
-0.52 -1.04 -0.81 -0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.30
price up icon 2.76%
$86.39
price up icon 1.86%
$31.72
price up icon 3.39%
$101.83
price up icon 3.29%
$147.52
price up icon 2.61%
biotechnology ONC
$343.50
price up icon 0.82%
Kapitalisierung:     |  Volumen (24h):